VisMederi Assays - VisMederi

Assays division of VisMederi deals with the creation, optimization, and standardization of bioanalytical microbiological, serological and virological assays and tests associated with vaccines’ immunogenicity assessment and epidemiological screening.

The VisMederi team guarantees proven experience in conducting a wide range of assays, including:

Serological assays for Influenza vaccines licensing in particular: HAI (Haemagglutinin Inhibition), SRH (Single Radial Haemolysis) and MN (Microneutralization)
Neutralization assay for emerging pathogens (Yellow Fever, Dengue, West Nile, etc. )
Antigenic Drift of influenza vaccine stocks
Pseudoparticle Neutralization assays(PPN)
Complement fixation assay
ELISA (Enzyme-Linked Immunosorbent Assay) assays for antigen and antibody detection
Immunofluorescence tests for detection of specific antibodies
Analysis of cell-mediated immune response using cytofluorometry (FACS) and ELISpot assay
LAL Test (Limulus Amebocyte Lysate) for the quantitative determination of endotoxins
Single Radial Diffusion Assay (SRD) for the quantification of viral antigens
Real Time RT-PCR
Serum Bactericidal Assay (SBA)
OPA-Assay (OPSONOPHAGOCYTIC ASSAY)

ELISA RBD / IgG – IgM – IgA
ELISA N / IgG – IgM – IgA
ELISA S1 / IgG – IgM – IgA
Neutralization assay (Wild Type virus)
Pseudoparticle Neutralization assay
SARS-CoV-2 cell-mediated immune response using cytofluorometry (FACS) and ELISpot assay
Elecsys® Anti-SARS-CoV-2 test
Real Time RT-PCR and viral isolation